Related Experiment Video
Updated: Sep 27, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Heterozygous CFTR variants associated with low-phospholipid-associated cholelithiasis phenotypes expand hepatobiliary
Camille Giannetti1, Louis Carmarans2, Patrice Bourgeois3
1Department of Biochemistry, AP-HM, Marseille, France.
Abstract:
Low-phospholipid-associated cholelithiasis (LPAC) syndrome is mainly associated with ABCB4 variants, although up to half of cases remain genetically unexplained. Given the role of CFTR in biliary homeostasis and its involvement in CFTR-related pancreatobiliary disorders, we investigated whether CFTR variants may contribute to LPAC phenotypes. We conducted a monocentric study including 34 patients fulfilling LPAC diagnostic criteria who underwent whole-exome sequencing with analysis restricted to an extended hepatobiliary gene panel including CFTR. Variants of interest were identified in 14/34 patients (41%), including 4 ABCB4 variant carriers (12%) and 10 CFTR variant carriers (29%). Patients carrying CFTR variants presented with classical LPAC features, including cholelithiasis, recurrent biliary symptoms, and cholangitis, while pancreatic involvement was observed in half of carriers. Compared with the CFTR carrier frequency estimated from the French newborn screening program (∼2.6%), CFTR variant carriers were significantly enriched in the cohort (11.5-fold enrichment, 95% CI 5.9-18.6, p < 0.001), suggesting a contributory role in a subset of LPAC phenotypes. These findings support consideration of CFTR in the genetic evaluation of selected patients with LPAC and reinforce the concept of hepatobiliary transporter disorders as a phenotypic continuum extending beyond ABCB4 deficiency.
More Related Videos
10:56A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
07:04Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
Published on: February 11, 2017
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cholecystitis
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Pharmacogenomics: Identification of New Drug Targets
Hepatic Drug Clearance: Role of Transporters
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu